This antibody was concentrated from hybridoma (clone 6F1) supernatant. This hybridoma was established by fusion of mouse myeloma cell P3U1 with Balb/c mouse splenocyte immunized with the recombinant human EGF-R cytoplasmic region (648-1186 aa).
Target:
EGF
Application Dilute:
WB: 1:1000-1:2000. IP: 2-5 µL/250 µL of cell extract from 5x106 cells. FCM: 1:100 (final concentration). ICC: 1:100
* VAT and and shipping costs not included. Errors and price changes excepted